New, Potent, Selective, and Short-Acting Peptidic V1a Receptor Agonists-Reference-Cited by-同舟云学术

New, Potent, Selective, and Short-Acting Peptidic V1a Receptor Agonists

Published:2011-06-20 Issue:13 Volume:54 Page:4388-4398
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wiśniewski Kazimierz¹,Galyean Robert¹,Tariga Hiroe¹,Alagarsamy Sudarkodi¹,Croston Glenn¹,Heitzmann Joshua¹,Kohan Arash¹,Wiśniewska Halina¹,Laporte Régent¹,Rivière Pierre J-M.¹,Schteingart Claudio D.¹

Affiliation:

1. Ferring Research Institute Inc., 4245 Sorrento Valley Boulevard, San Diego, California 92121, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm200278m

Reference54 articles.

1. Structural bases of vasopressin/oxytocin receptor function

2. Oxytocin and Vasopressin: Genetics and Behavioral Implications

3. Vasopressin Receptors

4. The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development

5. Vasopressin Stimulates Insulin Release from Islet Cells through V1b Receptors: a Combined Pharmacological/Knockout Approach

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants;PLOS ONE;2024-05-15

2. Oxytocin and vasopressin signaling in health and disease;Trends in Biochemical Sciences;2024-04

3. Chemical Strategies towards the Development of Effective Anticancer Peptides;Current Medicinal Chemistry;2024-04

4. Modified synthetic peptides: from therapeutics to chemosensors;Sensors & Diagnostics;2024

5. Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics;International Journal of Peptide Research and Therapeutics;2023-05-24